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Background: Subcutaneous fat aspirate for detection of systemic amyloidosis is a well-established screening method for immunoglobulin light-
chain amyloidosis (AL) and may make cardiac biopsy unnecessary if typical echocardiographic findings are present. At our institution this method 
has sensitivity of approximately 70% and specificity of 99% in AL patients. Cardiac involvement in mutant transthyretin (TTR-m) systemic amyloidosis 
is frequent and associated with high morbidity and mortality. Cardiac amyloidosis due to wild-type transthyretin (TTR-w) has also been described. 
Sensitivity of fat aspirate biopsy for detection of systemic amyloidosis in setting of cardiac biopsy-proven TTR-m and TTR-w is unknown.
methods: Subjects (n=124) were identified by retrospective review of the medical record at our institution. Inclusion required cardiac biopsy-
proven TTR amyloidosis, TTR genotyping and echocardiography. Subjects were grouped as either TTR-m or TTR-w by genotyping for comparison. Data 
summarized as mean±standard deviation for continuous variables or proportions for categorical variables with comparison by chi-square or two-
sample t-test.
results: 47 subjects with TTR-m and 77 with TTR-w were identified. Subjects with TTR-w were older at presentation (p <0.001). All subjects had 
typical echocardiographic findings of cardiac amyloidosis. However, TTR-m subjects had echocardiographic evidence of more advanced disease 
with worse ejection fraction (p=0.007), and greater septal thickness (p=0.04) and left ventricular mass index (p=0.01). 28 subjects with TTR-m 
and 53 with TTR-w underwent fat aspirate biopsy. Subcutaneous fat aspirate was positive in only 15 (54%) of TTR-m and 11 (21%) of TTR-w patients 
(p=0.003).
conclusion: Positive subcutaneous fat aspirate for detection of systemic amyloidosis due to TTR (TTR-m or TTR-w) may make cardiac biopsy 
unnecessary in some patients with typical echocardiographic features of cardiac amyloidosis. However, the low rate of positivity, particularly in 
patients with TTR-w, still requires cardiac biopsy in many patients.
